Rivaroxaban vascular Spirig HC 2.5 mg
Rivaroxaban vascular Spirig HC 2.5 mg is a medicine authorised by Swissmedic under authorisation number 68551. The authorisation holder is Spirig HealthCare AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 16 March 2023 and the authorisation is limited until 15 March 2028. ATC code B01AF01 places the medicine in the group Antithrombotic agents.
| Authorisation number | 68551 |
|---|---|
| Name | Rivaroxaban vascular Spirig HC 2.5 mg |
| Full name | Rivaroxaban vascular Spirig HC 2.5 mg, Filmtabletten |
| Authorisation holder | Spirig HealthCare AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | B01AF01 |
| First authorisation | 16 March 2023 |
| Authorisation validity | 15 March 2028 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Rivaroxaban vascular Spirig HC 2.5 mg, Filmtabletten | B | 16 March 2023 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 56 | Tablette(n) | B01AF01 | 06.03.0. | B |
| 2 | 196 | Tablette(n) | B01AF01 | 06.03.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Rivaroxaban vascular Spirig HC 2.5 mg authorised in Switzerland?
Yes. Rivaroxaban vascular Spirig HC 2.5 mg is authorised by Swissmedic under authorisation number 68551, data as of 01 September 2026. The authorisation is limited until 15 March 2028.
Which dispensing category does Rivaroxaban vascular Spirig HC 2.5 mg have?
Rivaroxaban vascular Spirig HC 2.5 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Rivaroxaban vascular Spirig HC 2.5 mg?
The authorisation holder is Spirig HealthCare AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.